The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2026
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Maslova N.N.

Smolensk State Medical University

Nikitenkova V.E.

Smolensk State Medical University

Gapeeva U.E.

Smolensk State Medical University

Shchukin P.A.

Smolensk State Medical University

Quality of life of patients with multiple sclerosis in the Smolensk region

Authors:

Maslova N.N., Nikitenkova V.E., Gapeeva U.E., Shchukin P.A.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12): 36‑40

DOI: 10.17116/jnevro202412412136

Read: 1160 times

Download PDF (RU)
Contact the author
Table of contents

QUALITY OF LIFE OF PATIENTS WITH MULTIPLE SCLEROSIS IN THE SMOLENSK REGION
QUALITY OF LIFE OF PATIENTS WITH MULTIPLE SCLEROSIS IN THE SMOLENSK REGION

To cite this article:

Maslova NN, Nikitenkova VE, Gapeeva UE, Shchukin PA. Quality of life of patients with multiple sclerosis in the Smolensk region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;124(12):36‑40. (In Russ.)
https://doi.org/10.17116/jnevro202412412136

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова (S.S. Korsakov Journal of Neurology and Psychiatry)
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Hormonal contraception methods and multiple scle­rosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):24-30
Epidemiology of multiple scle­rosis in the city of Novo­sibirsk. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(1):119-127
Comparing the effi­cacy of divo­zilimab and second-line treatments for rela­psing-remitting multiple scle­rosis in the Russian Fede­ration: a systematic review and network meta-analysis. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):58-68
Possibilities of using meldonium as part of complex therapy in patients with ischemic heart disease and chro­nic heart failure combined with obesity. Russian Journal of Cardiology and Cardiovascular Surgery. 2025;(1):53-60
Clinical effi­cacy of high-intensity magnetic therapy and transcutaneous electrical nerve stimulation in patients with diabetes mellitus and distal poly­neuropathy: a randomized study. Rege­nerative Biotechnologies, Preventive, Digi­tal and Predictive Medi­cine. 2025;(1):5-11
Effi­cacy and safety of mome­tasone and olopatadine combination for nasal use in patients with alle­rgic rhinitis caused by sensitization to epidermal alle­rgens in continuous expo­sure. Russian Rhinology. 2025;(1):48-56
Treatment of acute hemo­rrhoids acco­rding to the resu­lts of a multicenter obse­rvational study. Piro­gov Russian Journal of Surgery. 2025;(3):112-123
Vali­dation of the Russian version of the Caro­linas Comfort Scale in patients after previous abdo­minal hernia repair with mesh. Piro­gov Russian Journal of Surgery. 2025;(4):30-30
Prediction and prevention of burnout syndrome in health care professionals in high epidemic risk settings. Russian Journal of Preventive Medi­cine. 2025;(4):51-56
The effect of a gami­fication on healthy indi­viduals’ motor acti­vity. Russian Journal of Preventive Medi­cine. 2025;(4):111-116
Abstract:

OBJECTIVE

To study the quality of life (QoL) of patients with multiple sclerosis (MS) in the Smolensk region who receive MS disease-modifying therapies (DMT).

MATERIAL AND METHODS

The study included 37 patients receiving MS DMT. The 36-Item Short Form Health Survey (SF-36), the Multiple sclerosis Quality of Life (MusiQol), the Hamilton Depression Rating Scale, a scale of satisfaction with treatment, the Fatigue Severity Scale were administered.

RESULTS

The results of the survey showed a decrease in QoL of MS patients compared to the control group. The level of disability and the duration of the disease have the greatest impact on QoL. Factors such as sex, MS DMT, and the socio-economic status of the patient have less impact on QoL.

CONCLUSION

Given the priority impact of the level of disability on QoL of the patient, there is a need for earlier prescription of DMT to stop the progression of the disease.

Keywords:

multiple sclerosis
quality of life

Authors:

Maslova N.N.

Smolensk State Medical University

Nikitenkova V.E.

Smolensk State Medical University

Gapeeva U.E.

Smolensk State Medical University

Shchukin P.A.

Smolensk State Medical University

Received:

11.12.2023

Accepted:

11.07.2024

Close metadata

References:

  1. Boiko A.N., Bakhtiyarova K.Z., Sherman M.A. et al. Results of a study of the quality of life in patients with highly active multiple sclerosis In Russia. Neurology, Neuropsychiatry, Psychosomatics. 2022; 14 (1S):9-15. (In Russ.). https://doi.org/10.14412/2074-2711-2022-1S-9-15
  2. Malygin VL, Boĭko AN, Konovalova OE, et al. Influence of psychopathological factors and personality traits on the results of the study of quality of life in patients with multiple sclerosis. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(2-2):42-48. (In Russ.). https://doi.org/10.17116/jnevro20191192242
  3. Maslova NN, Pysina AM. Epidemiology of disseminated sclerosis in Smolensk Region. Bulletin of Siberian Medicine. 2008;7(5-1):236-238. (In Russ.). https://doi.org/10.20538/1682-0363-2008-5-1-236-238
  4. https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2/2015/8/downloads/ru/271997-729820150853  https://www.mediasphera.ru/issues/zhurnal-nevrologii-i-psikhiatrii-im-s-s-korsakova-2/2015/8/downloads/ru/271997-729820150853
  5. Sehanovic A, Kunic S, Ibrahimagic OC. et al. Contributing Factors to the Quality of Life in Multiple Sclerosis. Med Arch. 2020;74(5):368-373.  https://doi.org/10.5455/medarh.2020.74.368-373
  6. https://scienceeducation.ru/ru/article/view?id=7160 
  7. Balyazin VA, Goncharova ZA, Rudenko OYu. The factors which influence the multiply sclerosis patients’ quality of life. Sovremennyye problemy nauki i obrazovaniya. 2012;(5):56. Available from: https://scienceeducation.ru/ru/article/view?id=7160(InRuss.).
  8. Boĭko OV, Khoroshylova II, Petrov SV, et al. Changes in the quality of life in patients with multiple sclerosis treated with ocrelizumab. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(10-2):120-127. (In Russ.). https://doi.org/10.17116/jnevro201911910120
  9. Kalb R, Feinstein A, Rohrig A. et al. Depression and Suicidality in Multiple Sclerosis: Red Flags, Management Strategies, and Ethical Considerations. Curr Neurol Neurosci Rep. 2019;19(10):77.  https://doi.org/10.1007/s11910-019-0992-1
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.